• IgA Nephropathy: Current Treatment Landscape, Disease Burden, and 2-Year PROTECT Trial Data Supporting Sparsentan as an Emerging Treatment Option

チャート: Apple Podcasts – ガンビア – 教育

ガンビア の 教育 カテゴリ内の「IgA Nephropathy: Current Treatment Landscape, Disease Burden, and 2-Year PROTECT Trial Data Supporting Sparsentan as an Emerging Treatment Option」の過去の Apple Podcasts ランキング。